22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, today submitted a Modified Risk Tobacco Product (MRTP) application with the U.S. Food and Drug Administration (FDA) for the Company’s Very Low Nicotine Content (VLNC) cigarettes. 22nd Century’s proposed VLN™ cigarettes, the subject of the MRTP application, are made with the Company’s proprietary VLN™tobacco and, as a result, contain very low lev...